LiveMint-Keywords


17 lose licence to make obesity drug Radhieka Pandeya and Lison Joseph 12:31 AM \| November 25,2008 India’s drug regulator has cancelled licences granted to 17 companies to produce anti-obesity drug rimonabant FIND MORE ARTICLES ON: Anti-obesity drug Rimonabant Zydus Cadila Sun Pharmaceutical Torrent Pharmaceuticals Ranbaxy European Medicines Agency EU FDA